|
1
|
Global Burden of Disease Cancer
Collaboration; Fitzmaurice C, Allen C, Barber RM, Barregard L,
Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R,
Dandona L, et al: Global, regional, and national cancer incidence,
mortality, years of life lost, years lived with disability, and
disability-adjusted life-years for 32 cancer groups, 1990 to 2015:
A systematic analysis for the global burden of disease study. JAMA
Oncol. 3:524–548. 2017. View Article : Google Scholar
|
|
2
|
SEER Cancer Statistics Factsheets: Stomach
Cancer. National Cancer Institute; 2016
|
|
3
|
Arrington AK, Nelson R, Patel SS, Luu C,
Ko M, Garcia-Aguilar J and Kim J: Timing of chemotherapy and
survival in patients with resectable gastric adenocarcinoma. World
J Gastrointest Surg. 5:321–328. 2013. View Article : Google Scholar
|
|
4
|
Sakar B, Karagol H, Gumus M, Basaran M,
Kaytan E, Argon A, Ustuner Z, Bavbek SE, Bugra D and Aykan FN:
Timing of death from tumor recurrence after curative gastrectomy
for gastric cancer. Am J Clin Oncol. 27:205–209. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wagner AD, Unverzagt S, Grothe W, Kleber
G, Grothey A, Haerting J and Fleig WE: Chemotherapy for advanced
gastric cancer. Cochrane Database Syst Rev. Mar 17–2010.Epub ahead
of print. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Glover DM, Leibowitz MH, McLean DA and
Parry H: Mutations in aurora prevent centrosome separation leading
to the formation of monopolar spindles. Cell. 81:95–105. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nguyen AL and Schindler K: Specialize and
divide (twice): Functions of three aurora kinase homologs in
mammalian oocyte meiotic maturation. Trends Genet. 33:349–363.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sugimoto K, Urano T, Zushi H, Inoue K,
Tasaka H, Tachibana M and Dotsu M: Molecular dynamics of Aurora-A
kinase in living mitotic cells simultaneously visualized with
histone H3 and nuclear membrane protein importinalpha. Cell Struct
Funct. 27:457–467. 2002. View Article : Google Scholar
|
|
9
|
Sen S, Zhou H, Zhang RD, Yoon DS,
Vakar-Lopez F, Ito S, Jiang F, Johnston D, Grossman HB, Ruifrok AC,
et al: Amplification/overexpression of a mitotic kinase gene in
human bladder cancer. J Natl Cancer Inst. 94:1320–1329. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Staff S, Isola J, Jumppanen M and Tanner
M: Aurora-A gene is frequently amplified in basal-like breast
cancer. Oncol Rep. 23:307–312. 2010.PubMed/NCBI
|
|
11
|
Yang SB, Zhou XB, Zhu HX, Quan LP, Bai JF,
He J, Gao YN, Cheng SJ and Xu NZ: Amplification and overexpression
of Aurora-A in esophageal squamous cell carcinoma. Oncol Rep.
17:1083–1088. 2007.PubMed/NCBI
|
|
12
|
Kamada K, Yamada Y, Hirao T, Fujimoto H,
Takahama Y, Ueno M, Takayama T, Naito A, Hirao S and Nakajima Y:
Amplification/overexpression of Aurora-A in human gastric
carcinoma: Potential role in differentiated type gastric
carcinogenesis. Oncol Rep. 12:593–599. 2004.
|
|
13
|
Maehama T and Dixon JE: PTEN: A tumour
suppressor that functions as a phospholipid phosphatase. Trends
Cell Biol. 9:125–128. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ortega-Molina A and Serrano M: PTEN in
cancer, metabolism, and aging. Trends Endocrinol Metab. 24:184–189.
2013. View Article : Google Scholar
|
|
15
|
Maehama T and Dixon JE: The tumor
suppressor, PTEN/MMAC1, dephosphorylates the lipid second
messenger, phosphatidylino-sitol 3,4,5-trisphosphate. J Biol Chem.
273:13375–13378. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
VanderLaan PA, Rangachari D, Mockus SM,
Spotlow V, Reddi HV, Malcolm J, Huberman MS, Joseph LJ, Kobayashi
SS and Costa DB: Mutations in TP53, PIK3CA, PTEN and other genes in
EGFR mutated lung cancers: Correlation with clinical outcomes. Lung
Cancer. 106:17–21. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smith IN and Briggs JM: Structural
mutation analysis of PTEN and its genotype-phenotype correlations
in endometriosis and cancer. Proteins. 84:1625–1643. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu JC, Wang DY, Egan SE and Zacksenhaus
E: Common and distinct features of mammary tumors driven by
Pten-deletion or activating Pik3ca mutation. Oncotarget.
7:9060–9068. 2016.PubMed/NCBI
|
|
20
|
Mina S, Bohn BA, Simon R, Krohn A, Reeh M,
Arnold D, Bokemeyer C, Sauter G, Izbicki JR, Marx A and Stahl PR:
PTEN deletion is rare but often homogeneous in gastric cancer. J
Clin Pathol. 65:693–698. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta) C(T) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Wang J, Nikhil K, Viccaro K, Chang L,
White J and Shah K: Phosphorylation-dependent regulation of ALDH1A1
by aurora kinase a: Insights on their synergistic relationship in
pancreatic cancer. BMC Biol. 15:102017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pitts TM, Bradshaw-Pierce EL, Bagby SM,
Hyatt SL, Selby HM, Spreafico A, Tentler JJ, McPhillips K, Klauck
PJ, Capasso A, et al: Antitumor activity of the aurora a selective
kinase inhibitor, alisertib, against preclinical models of
colorectal cancer. Oncotarget. 7:50290–50301. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen C, Song G, Xiang J, Zhang H, Zhao S
and Zhan Y: AURKA promotes cancer metastasis by regulating
epithelial-mesenchymal transition and cancer stem cell properties
in hepatocellular carcinoma. Biochem Bioph Res Commun. 486:514–520.
2017. View Article : Google Scholar
|
|
25
|
Katsha A, Arras J, Soutto M, Belkhiri A
and El-Rifai W: AURKA regulates JAK2-STAT3 activity in human
gastric and esophageal cancers. Mol Oncol. 8:1419–1428. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
You D, Xin J, Volk A, Wei W, Schmidt R,
Scurti G, Nand S, Breuer EK, Kuo PC, Breslin P, et al: FAK mediates
a compensatory survival signal parallel to I3K-AKT in PTEN-null
T-ALL Cells. Cell Rep. 10:2055–2068. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang LY, He CY, Chen XH, Su LP, Liu BY and
Zhang H: Aurora kinase a revives dormant laryngeal squamous cell
carcinoma cells via FAK/PI3K/Akt pathway activation. Oncotarget.
7:48346–4859. 2016.PubMed/NCBI
|
|
28
|
Wang Y, Chen B, Wang Z, Zhang W, Hao K,
Chen Y, Li K, Wang T, Xie Y, Huang Z and Tong X: Marsdenia
tenacissimae extraction (MTE) inhibits the proliferation and
induces the apoptosis of human acute T cell leukemia cells through
inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.
Oncotarget. 7:82851–82863. 2016.PubMed/NCBI
|
|
29
|
Li JP, Yang YX, Liu QL, Pan ST, He ZX,
Zhang X, Yang T, Chen XW, Wang D, Qiu JX and Zhou SF: The
investigational aurora kinase a inhibitor alisertib (MLN8237)
induces cell cycle G2/M arrest, apoptosis, and autophagy via p38
MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Drug Des Devel Ther. 9:1627–1652. 2015.PubMed/NCBI
|
|
30
|
Jiang X and Li H: Overexpression of LRIG1
regulates PTEN via MAPK/MEK signaling pathway in esophageal
squamous cell carcinoma. Exp Ther Med. 12:2045–2052. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Puig-Butille JA, Vinyals A, Ferreres JR,
Aguilera P, Cabré E, Tell-Martí G, Marcoval J, Mateo F, Palomero L,
Badenas C, et al: AURKA overexpression is driven by FOXM1 and
MAPK/ERK activation in melanoma cells harboring BRAF or NRAS
mutations: Impact on melanoma prognosis and therapy. J Invest
Dermatol. 137:1297–1310. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zorba A, Buosi V, Kutter S, Kern N,
Pontiggia F, Cho YJ and Kern D: Molecular mechanism of aurora a
kinase autophosphorylation and its allosteric activation by TPX2.
Elife. 3:e026672014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shu LP, Zhou ZW, Zi D, He ZX and Zhou SF:
A SILAC-based proteomics elicits the molecular interactome of
alisertib (MLN8237) in human erythroleukemia K562 cells. Am J
Transl Res. 7:2442–2461. 2015.
|
|
34
|
Narbonne P, Maddox PS and Labbe JC:
DAF-18/PTEN signals through AAK-1/AMPK to inhibit MPK-1/MAPK in
feedback control of germline stem cell proliferation. PLoS Genet.
13:e10067382017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Benitez JA, Ma J, D'Antonio M, Boyer A,
Camargo MF, Zanca C, Kelly S, Khodadadi-Jamayran A, Jameson NM,
Andersen M, et al: PTEN regulates glioblastoma oncogenesis through
chromatin-associated complexes of DAXX and histone H3.3. Nat
Commun. 8:152232017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
de la Rosa J, Weber J, Friedrich MJ, Li Y,
Rad L, Ponstingl H, Liang Q, de Quirós SB, Noorani I, Metzakopian
E, et al: A single-copy sleeping beauty transposon mutagenesis
screen identifies new PTEN-cooperating tumor suppressor genes. Nat
Genet. 49:730–741. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shah MA: Gastrointestinal cancer targeted
therapies in gastric cancer-the dawn of a new era. Nat Rev Clin
Oncol. 11:10–11. 2014. View Article : Google Scholar
|
|
38
|
Shagisultanova E, Dunbrack RL Jr and
Golemis EA: Issues in interpreting the in vivo activity of
Aurora-A. Expert Opin Ther Targets. 19:187–200. 2015. View Article : Google Scholar
|
|
39
|
Ouchi M, Fujiuchi N, Sasai K, Katayama H,
Minamishima YA, Ongusaha PP, Deng C, Sen S, Lee SW and Ouchi T:
BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M
transition. J Biol Chem. 279:19643–19648. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kashatus DF, Lim KH, Brady DC, Pershing
NL, Cox AD and Counter CM: RALA and RALBP1 regulate mitochondrial
fission at mitosis. Nat Cell Biol. 13:1108–1115. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang K, Chen J, Chen D, Huang J, Feng B,
Han S, Chen Y, Song H, De W, Zhu Z, et al: Aurora-A promotes
chemoresistance in hepatocelluar carcinoma by targeting
NF-kappaB/microRNA-21/PTEN signaling pathway. Oncotarget.
5:12916–12935. 2014.PubMed/NCBI
|
|
42
|
Kwon YW, Kim IJ, Wu D, Lu J, Stock WA Jr,
Liu Y, Huang Y, Kang HC, DelRosario R, Jen KY, et al: Pten
regulates Aurora-A and cooperates with Fbxw7 in modulating
radiation-induced tumor development. Mol Cancer Res. 10:834–844.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cirak Y, Furuncuoglu Y, Yapicier O, Aksu A
and Cubukcu E: Aurora A overexpression in breast cancer patients
induces taxane resistance and results in worse prognosis. J BUON.
20:1414–1419. 2015.
|
|
44
|
Mignogna C, Staropoli N, Botta C, De Marco
C, Rizzuto A, Morelli M, Di Cello A, Franco R, Camastra C, Presta
I, et al: Aurora Kinase A expression predicts platinum-resistance
and adverse outcome in high-grade serous ovarian carcinoma
patients. J Ovarian Res. 9:312016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xu J, Yue CF, Zhou WH, Qian YM, Zhang Y,
Wang SW, Liu AW and Liu Q: Aurora-A contributes to cisplatin
resistance and lymphatic metastasis in non-small cell lung cancer
and predicts poor prognosis. J Transl Med. 12:2002014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kitano S, Shiraishi N, Uyama I, Sugihara K
and Tanigawa N; Japanese Laparoscopic Surgery Study G: A
multicenter study on oncologic outcome of laparoscopic gastrectomy
for early cancer in Japan. Ann Surg. 245:68–72. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yang SY, Roh KH, Kim YN, Cho M, Lim SH,
Son T, Hyung WJ and Kim HI: Surgical outcomes after open,
laparoscopic, and robotic gastrectomy for gastric cancer. Ann Surg
Oncol. 24:1770–1777. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Choi YY, Noh SH and Cheong JH: Evolution
of gastric cancer treatment: From the golden age of surgery to an
era of precision medicine. Yonsei Med J. 56:1177–1185. 2015.
View Article : Google Scholar : PubMed/NCBI
|
